Press Releases

Press Release

Cardiol Therapeutics Appoints Jennifer M. Chao to its Board of Directors

March 15, 2022

Press Release

Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite Patient Enrollment in the LANCER Trial

March 01, 2022

Press Release

Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory Board

January 19, 2022

Press Release

Cardiol Therapeutics Announces Closing of US$50 Million Public Offering

November 05, 2021

Press Release

Cardiol Therapeutics Announces Pricing of Public Offering of Units

November 03, 2021

Press Release

Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Units

November 02, 2021

Press Release

Cardiol Therapeutics Receives Health Canada Approval for Phase II Clinical Trial of CardiolRx™ for Acute Myocarditis

October 25, 2021

Press Release

Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx™, into Brazil, Mexico, and Canada

October 18, 2021

Press Release

Cardiol Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

September 16, 2021